Table 1.
Study | Cirrhotic patients | Controls | ||||||
---|---|---|---|---|---|---|---|---|
PSQI | ||||||||
Normal sleep: score >5 | Montagnese et al13 | 8* | 5 | |||||
Marques et al24 | 5 | 6 | ||||||
Heeren et al2 | 13* | 5 | ||||||
ESS | ||||||||
>10: excessive daytime sleepiness | Marques et al24 | 4 | 5 | |||||
Heeren et al2 | 10* | 7 | ||||||
SF-36 | ||||||||
<50: impaired QoL | Physical component summary | Mental component summary | Physical component summary | Mental component summary | ||||
Montagnese et al13 | 36* | 46* | 50 | 50 | ||||
Marques et al24 | 41* | 51 | 50 | 51 | ||||
Heeren et al2 (sum score, max value: 400) | 181* | 164* | 330 | 304 | ||||
Actigraphy | ||||||||
TIB (min) | SE (%) | WASO (min) | TIB (min) | SE (%) | WASO (min) | |||
Córdoba et al25 | 434 | 80* | 59* | 434 | 94 | 16 | ||
Marques et al24 | NA | 69* | NA | NA | 81 | NA | ||
Heeren et al2 | 500* | 81* | 86* | 441 | 85 | 58 |
Note:
P<0.05.
Abbreviations: PSQI, Pittsburgh Sleep Quality Index; ESS, Epworth Sleepiness Score; SF-36, 36-question shortform instrument; QoL, quality of life; TIB, time in bed; SE, sleep efficiency; WASO, wake after sleep onset; NA, not assessed.